Mefoxin

Active Ingredient(s): Cefoxitin
FDA Approved: * October 18, 1978
Pharm Company: * MERCK
Category: Antibiotics

Cefoxitin is a second-generation cephamycin antibiotic developed by Merck & Co., Inc. from Cephamycin C in the year following its discovery, 1972. It was synthesized in order to create an antibiotic with a broader spectrum.[3] It is often grouped with the second-generation cephalosporins.[4] Cefoxitin requires a prescription and as of 2010 is sold under the brand name Mefoxin by Bioniche Pharma, LLC. The generic version of cefoxitin is known as cefoxitin so... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Mefoxin 1 g/50ml Intravenous Injection, Solution
NDC: 67457-189
Labeler:
Bioniche Pharma USA LLC
Mefoxin 2 g/50ml Intravenous Injection, Solution
NDC: 67457-216
Labeler:
Bioniche Pharma USA LLC